Discovery of 7-Oxo-2,4,5,7-tetrahydro-6 H-pyrazolo[3,4- c]pyridine Derivatives as Potent, Orally Available, and Brain-Penetrating Receptor Interacting Protein 1 (RIP1) Kinase Inhibitors: Analysis of Structure-Kinetic Relationships

Journal of Medicinal Chemistry
Masato YoshikawaTakatoshi Yogo

Abstract

We report the discovery of 7-oxo-2,4,5,7-tetrahydro-6 H-pyrazolo[3,4- c]pyridine derivatives as a novel class of receptor interacting protein 1 (RIP1) kinase inhibitors. On the basis of the overlay study between HTS hit 10 and GSK2982772 (6) in RIP1 kinase, we designed and synthesized a novel class of RIP1 kinase inhibitor 11 possessing moderate RIP1 kinase inhibitory activity and P-gp mediated efflux. The optimization of the core structure and the exploration of appropriate substituents utilizing SBDD approach led to the discovery of 22, a highly potent, orally available, and brain-penetrating RIP1 kinase inhibitor with excellent PK profiles. Compound 22 significantly suppressed necroptotic cell death both in mouse and human cells. Oral administration of 22 (10 mg/kg, bid) attenuated disease progression in the mouse experimental autoimmune encephalomyelitis (EAE) model of multiple sclerosis (MS). Moreover, analysis of structure-kinetic relationship (SKR) for our novel chemical series was also discussed.

References

Oct 9, 2003·The Journal of Biological Chemistry·Francis Ka-Ming ChanMichael J Lenardo
Jan 13, 2006·Nature Chemical Biology·Alexei DegterevJunying Yuan
Feb 21, 2006·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·Hassan Pajouhesh, George R Lenz
Aug 5, 2006·Nature Reviews. Drug Discovery·Robert A CopelandThomas D Meek
May 10, 2007·Nature Protocols·Ingunn M Stromnes, Joan M Goverman
Apr 15, 2008·Nature Chemical Biology·Alexei DegterevJunying Yuan
Apr 17, 2008·Biochemistry·Peter J Tummino, Robert A Copeland
Mar 30, 2010·Journal of Medicinal Chemistry·Caterina BissantzMartin Stahl
Oct 22, 2010·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Hiroshi SugimotoToshiya Moriwaki
Dec 23, 2011·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Masanori NakakariyaYuichi Sugiyama
Oct 19, 2013·Journal of Chemical Information and Modeling·Suman SirimullaMahesh Narayan
May 14, 2014·The Journal of Immunology : Official Journal of the American Association of Immunologists·Scott B BergerPeter J Gough
Jun 6, 2014·ACS Medicinal Chemistry Letters·Philip A HarrisPeter J Gough
Jul 13, 2014·The Journal of Immunology : Official Journal of the American Association of Immunologists·Apostolos PolykratisMichelle A Kelliher
Mar 25, 2015·Cell Reports·Dimitry OfengeimJunying Yuan
May 30, 2015·Cell Death and Differentiation·D A RodriguezD R Green
Sep 4, 2015·Neural Regeneration Research·Jing-Ru WuYan-Bo Cheng
Nov 4, 2015·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Robert Roskoski
Dec 19, 2015·Nature Reviews. Drug Discovery·Robert A Copeland
Jan 3, 2016·Drug Discovery Today. Technologies·Andreas Schoop, Fabian Dey
Oct 26, 2016·Current Biology : CB·Kristin Politi, Serge Przedborski
Dec 22, 2016·Nature Reviews. Molecular Cell Biology·Ricardo WeinlichDouglas R Green
Jan 28, 2017·Trends in Pharmacological Sciences·Kelby W WegnerAlexei Degterev
Apr 7, 2017·Neurochemical Research·Lifei ShaoYilu Gao

❮ Previous
Next ❯

Citations

Nov 24, 2018·Nature Reviews. Neuroscience·Junying YuanDimitry Ofengeim
Apr 20, 2019·Medicinal Research Reviews·Xiangyi JiangPeng Zhan
Jul 23, 2019·Chemical Communications : Chem Comm·James E Kath, Aleksandra Baranczak
May 3, 2019·Proceedings of the National Academy of Sciences of the United States of America·Alexei DegterevJunying Yuan
Jun 15, 2019·International Journal of Molecular Medicine·Yuping LiuYi Wang
Mar 18, 2020·MedChemComm·Jim KüppersMichael Gütschow
Nov 8, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Eun-Jung InTae-Bong Kang
Jul 17, 2020·Nature Reviews. Drug Discovery·Lauren MifflinJunying Yuan
Oct 1, 2020·Cell Death and Differentiation·Sara DominguezBaris Bingol
Dec 1, 2020·Expert Opinion on Therapeutic Patents·Philip A Harris
Aug 1, 2020·Seminars in Cell & Developmental Biology·Gregory D Cuny, Alexei Degterev
Nov 30, 2020·European Journal of Medicinal Chemistry·Yuanyuan WangChunlin Zhuang
Jan 23, 2021·Journal of Medicinal Chemistry·Zhouling XieChenzhong Liao
Mar 6, 2021·Biochimica Et Biophysica Acta. Molecular Basis of Disease·Narjes ShahsavaniSoheila Karimi-Abdolrezaee
May 21, 2020·Journal of Medicinal Chemistry·Matthew D Lloyd
Apr 14, 2021·Future Medicinal Chemistry·Zhennan FangYiliang Li
May 1, 2021·European Journal of Medicinal Chemistry·Chunnian XiaChunlin Zhuang
Jun 5, 2021·RSC Medicinal Chemistry·Doris A SchuetzGerhard F Ecker
Mar 19, 2020·ACS Medicinal Chemistry Letters·Amy C HartWilliam J Pitts
Oct 18, 2019·Journal of Medicinal Chemistry·Chunlin Zhuang, Fener Chen
Jun 22, 2019·ACS Medicinal Chemistry Letters·Philip A HarrisRobert W Marquis
Sep 4, 2021·Journal of Medicinal Chemistry·Ricardo A M SerafimMatthias Gehringer

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.